Bovie Medical Co. (NYSE:BVX) dropped 3.6% on Tuesday . The stock traded as low as $4.28 and last traded at $4.34, with a volume of 423,614 shares trading hands. The stock had previously closed at $4.50.

BVX has been the subject of several recent analyst reports. Zacks Investment Research upgraded shares of Bovie Medical from a “sell” rating to a “hold” rating in a research note on Tuesday, July 19th. JMP Securities restated an “outperform” rating and issued a $5.00 target price on shares of Bovie Medical in a research note on Wednesday, August 3rd.

The company has a 50 day moving average of $2.53 and a 200-day moving average of $1.98. The company’s market capitalization is $121.73 million.

In related news, insider John J. Mccarthy III acquired 90,750 shares of the firm’s stock in a transaction dated Wednesday, August 17th. The shares were purchased at an average cost of $3.30 per share, for a total transaction of $299,475.00. Following the acquisition, the insider now owns 115,750 shares in the company, valued at approximately $381,975. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Bovie Medical Corporation (Bovie) is an energy-based medical device company. The Company is engaged in the design, development and manufacturing of electrosurgical equipment by producing equipment for medical device manufacturers through original equipment manufacturing (OEM) agreements, as well as start-up companies.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.